Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus.

MLA

Camp, Nicola J., et al. “Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus.” Cancer Research, vol. 76, no. 7, Apr. 2016, pp. 1916–25. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-15-1629.

APA

Camp, N. J., Lin, W.-Y., Bigelow, A., Burghel, G. J., Mosbruger, T. L., Parry, M. A., Waller, R. G., Rigas, S. H., Tai, P.-Y., Berrett, K., Rajamanickam, V., Cosby, R., Brock, I. W., Jones, B., Connley, D., Sargent, R., Wang, G., Factor, R. E., Bernard, P. S., … Cox, A. (2016). Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus. Cancer Research, 76(7), 1916–1925. https://doi.org/10.1158/0008-5472.CAN-15-1629

Chicago

Camp, Nicola J, Wei-Yu Lin, Alex Bigelow, George J Burghel, Timothy L Mosbruger, Marina A Parry, Rosalie G Waller, et al. 2016. “Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus.” Cancer Research 76 (7): 1916–25. doi:10.1158/0008-5472.CAN-15-1629.